PPD is now part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and PPD are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We now offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.
|
|
|
10,001+ employees
View all PPD employees
|
|
Research
|
|
929 North Front Street, Wilmington, NC 28401-3331, US
|
|
1985
|
|
Biotechnology, Clinical Research, Cro, Pharmaceutical, Pharmacovigilance, Consulting, Drug Development, Biostatistics, Therapeutics, Bioanalytical, Medical Writing, Biopharmaceutical, Laboratory, Early Development, Patient Recruitment, Drug Information, Biopharma, Functional Service Partnerships, Post-Approval
|
Katelyn Abernethy is the CEO of PPD. To contact Katelyn Abernethy email at [email protected].
The decision makers in PPD are Andrew Strayer, Cristina Muresan, Eugene Mcnally, etc. Click to Find PPD decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.